About Hanusch Krankenhaus
Das Hanusch-Krankenhaus befindet sich im 14. Wiener Gemeindebezirk in der Heinrich-Collin-Straße 30. Es ist ein Krankenhaus mit zehn Abteilungen und sieben Instituten, darunter das Ludwig-Boltzmann-Institut, ein Forschungsinstitut für Osteologie und Leukämie-Forschung.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arbeitsgemeinschaft medikamentoese Tumortherapie
8
German CLL Study Group
8
University of Ulm
8
AOP Orphan Pharmaceuticals AG
4
Celgene
4
Incyte Corporation
4
Vienna Institute for Research in Ocular Surgery
4
Austrian Breast & Colorectal Cancer Study Group
3
Boston Scientific Corporation
2
Hoffmann-La Roche
2
Jena University Hospital
2
Clinical Trials at Hanusch Krankenhaus
During the past decade, Hanusch Krankenhaus conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 14 clinical trials were completed, i.e. on
average, 31.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 7 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
2003-09-01
2005-10-01
Completed
206
Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia
1998-01-01
2012-04-01
Completed
169
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
2002-09-01
2009-12-01
Completed
17
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane
2000-09-01
2009-03-01
Completed
98
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid
1999-06-01
2018-06-26
Completed
1,803
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hanusch Krankenhaus" #1 sponsor was "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 8 trials, followed by "German CLL Study Group" with 8 trials
sponsored, "University of Ulm" with 8 trials sponsored, "AOP Orphan Pharmaceuticals AG" with 4 trials sponsored and "Celgene"
with 4 trials sponsored. Other sponsors include 52 different institutions and
companies that sponsored additional 47 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hanusch Krankenhaus"
#1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Amgen" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "Concept Medical Inc." with 2 trials as a collaborator and "CoreLab Black Forest" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were
collaborators in the rest 59 trials.
Clinical Trials Conditions at Hanusch Krankenhaus
According to Clinical.Site data, the most researched conditions in "Hanusch Krankenhaus" are
"Chronic Lymphocytic Leukemia" (7 trials), "Acute Myeloid Leukemia" (6 trials), "Peripheral Artery Disease" (5 trials), "Acute Myeloid Leukemia (AML)" (4 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Hanusch Krankenhaus" in a lesser frequency.
Clinical Trials Intervention Types at Hanusch Krankenhaus
Most popular intervention types in "Hanusch Krankenhaus" are "Drug" (60 trials), "Device" (15 trials), "Biological" (11 trials), "Other" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "Cytarabine" (6 trials), "Cyclophosphamide" (5 trials), "Placebo" (5 trials), "Rituximab" (5 trials) and "Fludarabine" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Hanusch Krankenhaus
The vast majority of trials in "Hanusch Krankenhaus" are
83 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hanusch Krankenhaus
Currently, there are NaN active trials in "Hanusch Krankenhaus".
undefined are not yet recruiting,
12 are recruiting,
16 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 50 completed trials in Hanusch Krankenhaus,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hanusch Krankenhaus, 6 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 41 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 13 trials that are defined as “Not Applicable".